Breaking News

Treatment satisfaction in pediatric atopic dermatitis after use of second generation antihistamines

Treatment satisfaction in pediatric atopic dermatitis after use of second generation antihistamines

 
 

An Argentinean study aimed to verify via a questionnaire, the efficacy of first and second generation antihistamines on the clinical symptoms, severity and patient quality of life of 45 pediatric atopic dermatitis (AD) patients. The primary outcome was the parents' satisfaction scores for efficacy, tolerability and global satisfaction; secondary outcomes were the physicians' scores on the same outcomes. Fexofenadine was the second generation antihistamine that was most preferred and effected significantly higher satisfaction scores and less somnolence than first generation agents. It also had less impact on the child's sleep and school activities (Alul, M. et al. 29th Congress Eur Acad Allergy Clin Immunol (June 5-9, London) 2010, Abst 1602).

 
to Continue Reading, Login Now
 

Please Login

 
 
  
 
 
If you are a registered user but you have forgotten your password, please click here
 
If you are not a registered user, please register here

return to breaking news list